Authors:
Sidwell, RW
Smee, DF
Bailey, KW
Burger, RA
Citation: Rw. Sidwell et al., Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice, INT IMMUNO, 1(6), 2001, pp. 1211-1218
Authors:
Smee, DF
Sidwell, RW
Morrison, AC
Bailey, KW
Baum, EZ
Ly, L
Wagaman, PC
Citation: Df. Smee et al., Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201, ANTIVIR RES, 52(3), 2001, pp. 251-259
Citation: Df. Smee et al., Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice, ANTIVIR RES, 52(1), 2001, pp. 55-62
Citation: Rw. Sidwell et al., Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201, ANTIVIR RES, 51(3), 2001, pp. 179-187
Authors:
Drusano, GL
Preston, SL
Smee, D
Bush, K
Bailey, K
Sidwell, RW
Citation: Gl. Drusano et al., Pharmacodynamic evaluation of RWJ-270201, a novel neuraminidase inhibitor,in a lethal murine model of influenza predicts efficacy for once-daily dosing, ANTIM AG CH, 45(7), 2001, pp. 2115-2118
Citation: Df. Smee et al., Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities, ANTIM AG CH, 45(3), 2001, pp. 743-748
Citation: Rw. Sidwell et al., In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RWJ-270201, ANTIM AG CH, 45(3), 2001, pp. 749-757
Authors:
Song, GY
Paul, V
Choo, H
Morrey, J
Sidwell, RW
Schinazi, RF
Chu, CK
Citation: Gy. Song et al., Enantiomeric synthesis of D- and L-cyclopentenyl nucleosides and their antiviral activity against HIV and West Nile virus, J MED CHEM, 44(23), 2001, pp. 3985-3993
Citation: Df. Smee et al., Treatment of cowpox virus respiratory infections in mice with ribavirin asa single agent or followed sequentially by cidofovir, ANTIVIR CHE, 11(4), 2000, pp. 303-309
Authors:
Burger, RA
Billingsley, JL
Huffman, JH
Bailey, KW
Kim, CU
Sidwell, RW
Citation: Ra. Burger et al., Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice, IMMUNOPHARM, 47(1), 2000, pp. 45-52
Authors:
Fatemi, SH
Emamian, ES
Kist, D
Sidwell, RW
Nakajima, K
Akhter, P
Shier, A
Sheikh, S
Bailey, K
Citation: Sh. Fatemi et al., Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice, MOL PSYCHI, 4(2), 1999, pp. 145-154
Authors:
Morrey, JD
Bailey, KW
Korba, BE
Sidwell, RW
Citation: Jd. Morrey et al., Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine, ANTIVIR RES, 42(2), 1999, pp. 97-108
Authors:
Barnard, DL
Sidwell, RW
Xiao, W
Player, MR
Adah, SA
Torrence, PF
Citation: Dl. Barnard et al., 2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection, ANTIVIR RES, 41(3), 1999, pp. 119-134
Authors:
Jackson, MK
Mitchell, EA
Winslow, SG
Okelberry, KM
Sidwell, RW
Morrey, JD
Citation: Mk. Jackson et al., Resistance to friend leukemia virus in transgenic mice expressing the native FV-4 gene, ACT VIROLOG, 43(1), 1999, pp. 19-23
Authors:
Tai, CY
Escarpe, PA
Sidwell, RW
Williams, MA
Lew, W
Wu, HW
Kim, CU
Mendel, DB
Citation: Cy. Tai et al., Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071., ANTIM AG CH, 42(12), 1998, pp. 3234-3241
Citation: Jd. Morrey et al., Transgenic mice as a chemotherapeutic model for hepatitis B virus infection, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 161-170